Previous Article in Journal / Special Issue
Managing Bariatric Surgery Complications at a Third Level Public Hospital in Panamá
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Transeptal Puncture Complications: What to Watch for and How to Avoid Them

by
Nicolò Azzola Guicciardi
1,*,
Carlotta De Carlo
2 and
Francesco Maisano
1
1
Department of Cardiac Surgery, Valve Center—IRCCS San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy
2
Department of Cardiology, Clinica Sanatrix, 00199 Rome, Italy
*
Author to whom correspondence should be addressed.
Complications 2025, 2(2), 14; https://doi.org/10.3390/complications2020014
Submission received: 5 February 2025 / Revised: 15 April 2025 / Accepted: 4 June 2025 / Published: 16 June 2025

Abstract

:
Transseptal puncture (TSP) is an essential step for left heart procedures that allows access to the left atrium (LA) through the fossa ovalis (FO) of the interatrial septum (IS). Initially developed for diagnostic purposes, today, it is performed for procedures that require large-bore device delivery systems and complex three-dimensional navigation in the left atrium. TSP supports various interventions, including atrial fibrillation ablation, left atrial appendage closure, and transcatheter mitral valve repair and replacement. While traditionally performed with Brockenbrough needles under fluoroscopic guidance, the integration of transesophageal and intracardiac echocardiography (TEE/ICE) has significantly improved its safety and precision. Despite its generally high success rate, TSP poses challenges in complex anatomies or for less experienced operators, with complications such as cardiac tamponade, aortic root puncture, and embolic events. Anatomical variations, such as thickened or floppy septa, further complicate the procedure. Technological advancements, including radiofrequency-based systems and specialized guidewires, have enhanced safety in difficult cases. Effective training, including echocardiography and complication management, is vital for operator proficiency. This review outlines the procedural steps for safe TSP, emphasizing proper equipment selection, anatomical considerations, and vascular access techniques. Common complications are discussed alongside management strategies. Advanced tools and techniques for addressing challenging scenarios are highlighted.

1. Introduction

Transseptal puncture (TSP) is performed to access the left atrium (LA) from the systemic venous system by traversing the fossa ovalis (FO) within the interatrial septum (IS), Figure 1. This approach enables the use of larger devices with improved maneuverability compared to retrograde arterial cannulation.
First introduced by Ross et al. as a diagnostic method in candidate patients for cardiac surgery [1,2], over the years, TSP has been employed in the electrophysiology lab for atrial fibrillation ablation, followed by procedures addressing left atrial tachycardias, left-sided accessory pathways, and left ventricular arrhythmias. TSP has also gained traction in percutaneous cardiac interventions, such as left atrial appendage closure, mitral valve repair, and transcatheter mitral annuloplasty.
Traditionally, TSP is performed using Brockenbrough needles under fluoroscopic guidance, often supplemented by transesophageal or intracardiac echocardiography (TEE/ICE). In the hands of experienced operators, the procedure is generally safe and highly successful, with an overall complication rate of approximately 1% [3,4]. However, the technique can be challenging, particularly for less experienced practitioners or in cases of complex anatomies, posing risks of severe and potentially life-threatening complications.
To minimize these risks, it is crucial to understand the anatomy of the fossa ovalis, recognize situations that might make the procedure more challenging, and leverage tools designed to enhance safety and ease of use. The timely identification and management of TSP-related complications are vital. This review explores the most common TSP complications, their management, and the anatomical variations that increase procedural difficulty. It also highlights the techniques and technologies available to ensure safer and more effective traversal of the FO.

2. How to Perform a Safe Transeptal Puncture

2.1. Materials and Equipment

The original needle introduced by Ross featured a curved distal end for controlled tip movement and an arrow-shaped proximal handle for orientation. Brockenbrough later modified this design, tapering the distal 1.5 cm from 18 to 21 gauge [5,6]. The modern Brockenbrough (BRK) needle, made of stainless steel with a stylet to reduce friction, comes in standard (19° angle) and BRK 1 (53° angle) versions, with customizable curvature and pediatric options.
Common sheaths for use with BRK needles are the Mullins and Swartz™ Braided SL (Abbott, Chicago, IL, USA). The Swartz SL offers a better pushability and torquability, suitable for targeting the superior left pulmonary vein, while the Mullins sheath is better suited for reaching the mitral valve. Today, various manufacturers produce transseptal kits with slight design differences.

2.2. Atrial Septum Anatomy and Fossa Ovalis

The IS includes the entire area between the two atria but differs from the “true” IS, which is the portion that can be safely crossed without entering the extracardiac space—only about 20% of the total septal area [7].
The fossa ovalis, part of the true IS, is in the lower posterior IS and is typically an oval or occasionally round depression made of thin fibrous tissue. It can be divided into the following four regions: superior–anterior, inferior–anterior, superior–posterior, and inferior–posterior. Its shape varies based on atrial size, pressure, and tissue redundancy. The optimal TSP location varies according to the procedure. The fossa ovalis is surrounded by a muscular septum. The superior rim of the septum coincides with the superior vena cava, the anterior rim with the aortic valve and ascending aorta, the inferior rim with the inferior vena cava, and the posterior rim with the interatrial fold (also known as the Waterstone or Sondergaards groove). This is a portion of the atria wall in which the roofs of the left and right atrial wall fold are anteriorly separated by fat tissue. When TSP is performed in this region, there is a risk of perforating both atrial walls and the extramural epicardium with the risk of immediate or delayed tamponade.

2.3. Vascular Access Management

The first step of the TSP procedure is venous femoral puncture, typically performed on the right side for a more direct path to the right atrium (RA). However, both groins should be prepped, as the left side may be needed for invasive arterial monitoring, managing complications, or as an alternative access site in cases of unfavorable right venous anatomy.
The femoral head serves as the fluoroscopic landmark (AP projection), with the puncture positioned medial to it and below its equator. Alternatively, the femoral pulse can be palpated, and the puncture is made 4 cm below the inguinal ligament, medial to the pulse, at a 45° angle.
More recently, an echo-guided approach has been recommended to avoid vascular complications (inadvertent arterial puncture, lesions of the femoral artery collaterals, or artero-venous fistula). Echo-guided puncture allows for the identification of a safe area, usually cranial to the arterial bifurcation, where the vein is medial to the artery. Following venous puncture, preclosure with one or more suture-based closure device (ProGlide, ProStar, Prostyle by Abbott Vascular, Santa Clara, CA, USA, and Manta by Teleflex, Wayne, PA, USA) is recommended in the case of the insertion of large bore devices. Administering 2000 U of heparin (about 1/4 of the total dose) at this stage helps to prevent clot deposition on the TSP sheath, particularly if the procedure is prolonged, if TSP is expected to be challenging, with multiple “pull-back” maneuvers, or in the case of less experienced operators. If preclosure devices are not available or in the case of their failure, a “figure of eight” suture may serve adequately as a vascular vein closure strategy.

2.4. Transeptal Puncture Step by Step

A 0.0032 guidewire is advanced in the superior vena cava. A 12F introducer sheath can be used, but in echo-guided TSP, it is not mandatory, since no tactile feedback will be needed to confirm septal engagement. The transseptal sheath and dilator are advanced over the guidewire to reach the superior vena cava (SVC) under fluoroscopic (AP projection) and TEE (bicaval view) guidance, as shown in Figure 1. For cases involving pacemaker electrodes, to position the guidewire posterior to the leads, the advancement of the guidewire is performed in the LAO projection. When advancing the sheath, the tip is aimed leftward (toward the aorta) to avoid the cava free wall.
In cases of venous tortuosity (typical for patients with calcific peripheral arterial disease), a larger sheath and a stiff buddy wire can be used to straighten the vein.
The BRK needle is shaped according to the right atrial and fossa ovalis anatomy and the desired position of the transeptal puncture. Under fluoroscopic guidance, the BRK needle is carefully advanced until it reaches the sheath tip, avoiding overextension. The stylet remains in place to reduce friction, and the needle should rotate freely during insertion to navigate vascular tortuosity. Once the stylet is removed, the needle can be connected to a pressure line.
Then, a “pull-back” maneuver begins with the needle arrow pointing at 5 or 6 o’clock. For posterior punctures, the arrow is maintained at 6 o’clock. It is then pulled back caudally until the needle tents the superior rim of the fossa, observed via TEE, as shown in Figure 2. Proper tenting is typically accompanied by supraventricular extrasystolic beats. Pulling the device back a few more centimeters will result in the needle falling in the fossa. Optimal puncture locations depend on the type of procedure, device used, and anatomy.
Using TEE (SAX view) and fluoroscopy (AP projection), the needle punctures the fossa ovalis, verified by a loss of tenting on TEE and left atrial pressure confirmation. Advancing the sheath should be avoided without proper pressure tracing or if aortic pressure is detected. In experienced hands, pressure monitoring can be avoided in TEE-guided procedures, however, pressure tracing enables greater safety. Full heparinization (100 U/kg) should be administered to maintain an activated clotting time (ACT) of 250–300 s.
The sheath and needle are advanced 1–2 cm into the LA under TEE guidance. The following tips and tricks may be useful:
-
Use fluoroscopy and TEE to confirm positioning at every step.
-
Maintain slow, controlled movements to avoid sheath displacement.
-
Always verify the correct puncture position using TEE, blood aspiration, pressure curves, or contrast injection before advancing the sheath.

3. Most Frequent Complications and How to Handle Them

3.1. Posterior Transeptal Puncture and Cardiac Tamponade

Cardiac tamponade is the most frequent life-threatening complication of TSP, occurring in approximately 1% of cases [8,9]. It is often caused by misdirected needle punctures, such as posterior wall perforation or through-and-through punctures of the left atrium due to excessive force or redundant/aneurysmal septum anatomy. The risk is higher during AF ablation due to multiple punctures, extensive catheter manipulation, and ongoing anticoagulation. Symptoms include sudden hypotension, hypoxia, sinus tachycardia, and cardiogenic shock, and diagnosis is confirmed with TTE or TEE. Tamponade may occur acutely during the procedure or present as delayed tamponade after catheter removal, often associated with atrial hematomas [10].
The prevention of wrong punctures is crucial, and the risk of tamponade is mitigated by careful TEE guidance and some other measures. In the case of risk, advancing a 0.0018” guidewire through the Brockenbrough needle can avoid inadvertent punctures while advancing the needle following the initial puncture. Another measure to reduce the risk of lesions is the use of RF-energy-supported TSP in the case of a floppy or post-cardiotomy septum, under strict echo-guidance.
Management involves reversing anticoagulation, fluid administration, and pericardiocentesis, with blood transfusion if needed. In severe cases, surgical drainage may be required for large tears or clotted blood. Treatment includes pericardial drainage and closure of the bleeding site using an atrial septum defect closure device.
For mitral procedures requiring posterior TSP, punctures near the muscular septum can lead to pericardial effusion or tamponade. Early detection is crucial; in case of doubt, at the end of the TEER procedure, a wire is readvanced through the guiding catheter and the guide is retracted in the right atrium, with the dilator ready to be able to readvance the catheter in the case of pericardial effusion. In total, 3–5 min of observation time is needed under TEE and hemodynamics monitoring. The guiding catheter will then control the bleeding and allow time to prepare an atrial septal occluder (ASD type), which will be used to definitively control the bleeding by sandwiching the walls.

3.2. Aortic Needle Puncture

Inadvertent aortic root puncture during TSP is a rare but potentially life-threatening complication, occurring in approximately 0.05% of cases [11]. The aortic root, located anterosuperiorly to the FO, can be at risk of puncture due to anatomical variations or abnormal heart rotation, where the FO may be situated closer to the aortic root. This complication is more likely in challenging anatomies, anterior punctures, or with insufficient operator experience [12]. TEE or ICE guidance significantly reduces this risk [11].
Proper needle positioning can be confirmed by pressure recording or contrast injection. If an aortic puncture is identified, the dilator and sheath must not be advanced until the needle placement is verified. In cases where only the needle has entered the aorta, slow withdrawal is usually sufficient. However, if the dilator or sheath has advanced, the risk of complications such as hemopericardium increases. It is crucial to avoid pulling back the dilator if this has been already advanced in the aorta, since this will result in instantaneous tamponade and inability to manage the patient.
Management strategies vary depending on the extent of the injury [11]. Some cases have required surgical repair, such as valve replacement due to persistent shunts or the stitching of perforations [13]. Alternatively, occluder devices have been used successfully to close aortic perforations [14], however, this option is not feasible when the puncture is close to the aortic valve leaflets. In borderline cases, leaving a guidewire in the aorta followed by observation allows for rapid re-advancement of the sheath and bleeding control [15]. Monitoring hemodynamics and echocardiographic findings during a waiting period may prevent further deterioration. These measures, along with careful procedural planning, are crucial for handling this rare but critical complication.

3.3. Embolic Events

Air and thrombus embolisms are uncommon complications of TSP, but they can arise due to the improper de-airing of large devices or inadequate anticoagulation [16]. Thrombus formation can occur in the space between the needle and dilator, particularly when the TSP system reaches the left heart. Air embolism may result from persistent air bubbles in the system, insufficient flushing, or the presence of a PFO. Also, advancement of the needle without the stylet can produce plastic debris that can embolize.
To minimize these risks, the meticulous flushing of sheaths and effective anticoagulation are essential. Heparin (1000–2000 IU) should be administered intravenously before TSP to prevent thrombus formation when a long time for TSP is anticipated.
Management strategies for thromboembolic events depend on their severity and location. For thrombus formation, a full heparin dose targeting an ACT >250 s should be administered and thrombus aspiration may be attempted, especially before crossing the septum. If the thrombus reaches the left heart, cerebral protection devices may be considered, and large thrombi might necessitate surgical intervention.
The careful de-airing of devices and systems in paramount to prevent air embolism. Silent cerebrovascular ischemia remains a concern during transcatheter left-heart procedures, emphasizing the importance of rigorous intra-procedural anticoagulation and air management to minimize embolic risks [17].

3.4. ST-Segment Elevation

Isolated transient ST elevation in inferior leads occurs in approximately 0.6% of TSP cases and is often accompanied by vagal symptoms, including bradycardia, hypotension, and diaphoresis. This phenomenon typically resolves within 3–5 min without a rise in troponin levels. It is primarily attributed to a Bezold–Jarisch-like reflex caused by mechanical stimulation of the vagal network near the puncture site. The parasympathetic fibers in this region, which preferentially innervate the right coronary artery, may induce cholinergic vasospasm.
An alternative explanation is coronary air embolism. Gas embolism can be observed when using a diathermia on the needle to electrify the Brockenbrough needle, rather than using a dedicated RF device. Recovery can be spontaneous, but atropine or adrenaline administration is often required. If ST elevation persists, air or thrombus embolisms should be considered and managed accordingly. Proper diagnosis and prompt recognition are essential to avoid unnecessary invasive interventions.

3.5. Residual Iatrogenic Atrial Septal Defect

Residual iatrogenic ASDs are a frequent long-term complication of TSP, with sheath size being the strongest predictor [18].
Persistent ASDs after transcatheter mitral valve interventions can have detrimental outcomes, including worsened heart failure, elevated NT-proBNP levels, and reduced six-month survival. In some cases, right-to-left or bidirectional shunts and large atrial septal defects (ASDs) (>8 mm) necessitate closure, especially after procedures that require large-bore sheaths and septal dilation. Patients with right-to-left shunts are at a higher risk of complications such as paradoxical embolism, stroke, and systemic embolization, and empiric anticoagulation may be necessary [19].
Management strategies for residual ASDs depend on the defect’s size, shunting direction, and associated symptoms. Symptomatic patients, especially those with refractory hypoxemia, cryptogenic stroke, or worsening heart failure, should undergo percutaneous closure, typically with an Amplatzer device, which has favorable anatomical outcomes [19]. Although prophylactic closure has been suggested for all patients undergoing mitral transcatheter edge to edge (TEER) procedures, evidence supporting this approach remains limited [20]. TEE is essential for detecting ASDs and assessing shunt severity, offering morphological and size evaluations. However, long-term follow-up data on ASD natural history are still limited [20].

4. How to Deal with Challenging Scenarios

4.1. Floppy Septum

Due to the pliability of the membranous septum (Video S1), the height of the puncture may decrease when steering devices. Consequently, in cases where the septum is particularly flexible, opting for a higher puncture point is advisable. As mentioned above, a floppy septum, when pushed by the TSP device, can get into contact with the roof of the left atrium or even the appendage. To mitigate this issue, alternative approaches to standard techniques can be employed, such as utilizing a diathermy surgical system or an RF transseptal system (Baylis Medical, RF Transseptal Kit, Baylis Medical, Montreal, QC, Canada), which improves the safety and accuracy of the puncture by reducing the need for pressure to penetrate the left atrium.

4.2. Enlarged Atria

When dealing with enlarged atria, the TSP should be positioned less inferiorly and posteriorly to prevent entry into the LA in a too-high position. In situations where the pre-shaped curvature of the needle does not adequately reach the interatrial septum, manually adding curvature to the needle may assist in successfully reaching the target area.

Thick Septum

When performing a redo procedure after cardiac surgery or thoracic radiation, crossing the interatrial septum can be more challenging due to increased resistance. In such scenarios, alternative tools and techniques may be utilized. One option involves using the back end of a 0.014-inch exchange angioplasty wire, such as the BMW Universal (Abbott Vascular) [21]. Another technique consists of applying radiofrequency (RF) energy to the proximal part of the needle using an electrosurgical cautery generator. The SafeSept Needle-Free Transseptal Guidewire (Pressure Products Medical Supplies Inc., San Pedro, CA, USA) has also been evaluated [22,23]. This nitinol guidewire is specifically designed to facilitate safer and more efficient transseptal punctures. Its sharp tip allows for easy perforation and crossing of the fossa, and when paired with a transseptal dilator and introducer, it enables initial puncture of the interatrial septum without requiring a traditional transseptal needle. Once unsupported by the dilator and sheath, the tip of the guidewire assumes a “J” shape, preventing further tissue penetration [24]. Additionally, RF-based technology, such as the Baylis radiofrequency transseptal system, has been developed. This system replaces the traditional Brockenbrough needle with an RF catheter inserted into the dilator/sheath assembly (TorFlex™ Transseptal Guiding Sheath, Baylis Medical). This method can be particularly advantageous in cases of thickened, scarred, calcified, or patched septa, where excessive force increases the risk of unsuccessful puncture. In such situations, the momentum of the needle and sheath may result in overshooting, inadvertently puncturing the superior or contralateral wall of the LA once the system crosses the septum.

4.3. Previous Transeptal Puncture

Redo TSP at sites of prior crossings presents a distinct set of challenges. Comparative studies consistently show that repeat punctures are technically more demanding and associated with higher failure rates [25]. This difficulty arises primarily due to local inflammatory responses at the previous TSP site, leading to tissue scarring and increased stiffness of the IS. Notably, tissue stiffness, rather than thickness, is a key factor contributing to the increased complexity of redo TSP. The extent of scarring is influenced by the duration of the initial procedure and the interval between the first and subsequent interventions.
Similarly, using a PFO as the crossing portal complicates repeat procedures and may result in a complete loss of patency [25]. For puncturing thickened septa, wide-angle needles such as the BRK-1 needle with a 53° curvature can be advantageous. These needles reduce upward slippage and direct the force perpendicular to the septum. Advancing the sheath through a stiff and fibrotic septum may also be challenging due to the atraumatic design of sheath tips. However, these difficulties can usually be resolved by applying manual pressure, bending the sheath to its maximum curvature, and pulling it downward to widen the transseptal access.

5. Mastering Transeptal Puncture

TSP is a critical skill in structural heart interventions, requiring precision to avoid complications. Mastery begins with a thorough understanding of anatomy, fluoroscopy, and echocardiography (TEE/ICE) for real-time visualization.
Simulation-based training provides a safe, effective way to develop proficiency before performing the procedure in patients. Post-procedural echo is essential to confirm correct access and detect potential complications early. A structured learning pathway combining didactic education, hands-on simulation, and supervised clinical practice minimizes adverse events and ensures procedural success and effectiveness. Moreover, in high-volume centers, mortality and complication rates significantly decrease [26], emphasizing the importance of experience and institutional expertise in achieving optimal outcomes.

6. Conclusions

While the technique and equipment for TSP have remained largely unchanged since their introduction in the late 1950s, the increasing use of TSP and the demand for safer and more precise punctures have led to the development of new devices and technique refinements. One of the most significant advancements has been the incorporation of intraprocedural echocardiography, which enhances precision and safety while enabling less experienced operators to perform TSP with greater confidence. Combining fluoroscopic imaging with transesophageal echocardiography can further streamline the procedure.
Despite these advancements, complications and challenges can still arise, underscoring the importance of a thorough understanding of each procedural step and potential complication.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/complications2020014/s1, Video S1. Imaging of a Floppy Septum. A floppy septum is a common and challenging scenario during TSP. The CT scan and transesophageal echocardiography (TEE) provide detailed visualization of the septal movement throughout the cardiac cycle, aiding in procedural planning and execution.

Author Contributions

Conceptualization, N.A.G. and F.M.; validation C.D.C.; writing—original draft preparation, N.A.G. and F.M.; writing—review and editing, F.M. and C.D.C.; visualization, C.D.C.; supervision, F.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

Nicolò Azzola Guicciardi—none. Carlotta De Carlo—employee and shareholder of Roche Diagnostics International, Rotkreuz, Switzerland. Francesco Maisano—Grant and/or Research Institutional Support from Abbott, Medtronic, Edwards Lifesciences, Biotronik, Boston Scientific Corporation, NVT, Terumo, Venus, Roche. Consulting fees, Honoraria personal and Institutional from Abbott, Boston Scientific, Medtronic, Edwards Lifesciences, Xeltis, Cardiovalve, Occlufit, Simulands, Mtex, Venus, Squadra, Valgen, croivalve. Royalty Income/IP Rights Edwards Lifesciences. Shareholder (including share options) of Magenta, Transseptalsolutions, 4Tech.

References

  1. Ross, J.; Braunwald, E.; Morrow, A.G. Transseptal left atrial puncture. Am. J. Cardiol. 1959, 3, 653–655. [Google Scholar] [CrossRef] [PubMed]
  2. Ross, J.; Braunwald, E.; Morrow, A.G. Transseptal left heart catheterization: A new diagnostic method. Prog. Cardiovasc. Dis. 1960, 2, 315–318. [Google Scholar] [CrossRef] [PubMed]
  3. De Ponti, R.; Cappato, R.; Curnis, A.; Della Bella, P.; Padeletti, L.; Raviele, A.; Santini, M.; Salerno-Uriarte, J.A. Trans-Septal Catheterization in the Electrophysiology Laboratory. J. Am. Coll. Cardiol. 2006, 47, 1037–1042. [Google Scholar] [CrossRef] [PubMed]
  4. Fagundes, R.L.; Mantica, M.; De Luca, L.; Forleo, G.; Pappalardo, A.; Avella, A.; Fraticelli, A.; Russo, A.D.; Casella, M.; Pelargonio, G.; et al. Safety of Single Transseptal Puncture for Ablation of Atrial Fibrillation: Retrospective Study from a Large Cohort of Patients. J. Cardiovasc. Electrophysiol. 2007, 18, 1277–1281. [Google Scholar] [CrossRef]
  5. Brockenbrough, E.G.; Braunwald, E. A new technic for left ventricular angiocardiography and transseptal left heart catheterization. Am. J. Cardiol. 1960, 6, 1062–1064. [Google Scholar] [CrossRef]
  6. Brockenbrough, E.C.; Braunwald, E.; Ross, J. Transseptal Left Heart Catheterization: A Review of 450 Studies and Description of an Improved Technic. Circulation 1962, 25, 15–21. [Google Scholar] [CrossRef]
  7. Klimek-Piotrowska, W.; Hołda, M.K.; Koziej, M.; Piątek, K.; Hołda, J. Anatomy of the true interatrial septum for transseptal access to the left atrium. Ann. Anat.-Anat. Anz. 2016, 205, 60–64. [Google Scholar] [CrossRef] [PubMed]
  8. Katritsis, G.D.; Siontis, G.C.M.; Giazitzoglou, E.; Fragakis, N.; Katritsis, D.G. Complications of transseptal catheterization for different cardiac procedures. Int. J. Cardiol. 2013, 168, 5352–5354. [Google Scholar] [CrossRef]
  9. O’Brien, B.; Zafar, H.; De Freitas, S.; Sharif, F. Transseptal puncture—Review of anatomy, techniques, complications and challenges. Int. J. Cardiol. 2017, 233, 12–22. [Google Scholar] [CrossRef]
  10. Cappato, R.; Calkins, H.; Chen, S.A.; Davies, W.; Iesaka, Y.; Kalman, J.; Kim, Y.-H.; Klein, G.; Natale, A.; Packer, D.; et al. Delayed Cardiac Tamponade After Radiofrequency Catheter Ablation of Atrial Fibrillation. J. Am. Coll. Cardiol. 2011, 58, 2696–2697. [Google Scholar] [CrossRef]
  11. Wasmer, K.; Zellerhoff, S.; Köbe, J.; Mönnig, G.; Pott, C.; Dechering, D.G.; Lange, P.S.; Frommeyer, G.; Eckardt, L. Incidence and management of inadvertent puncture and sheath placement in the aorta during attempted transseptal puncture. Europace 2017, 19, 447–457. [Google Scholar] [CrossRef] [PubMed]
  12. Salghetti, F.; Sieira, J.; Chierchia, G.B.; Curnis, A.; De Asmundis, C. Recognizing and reacting to complications of trans-septal puncture. Expert. Rev. Cardiovasc. Ther. 2017, 15, 905–912. [Google Scholar] [CrossRef] [PubMed]
  13. Seppelt, P.; Karck, M.; Kallenbach, K. Aortic Mispuncture during Routine Catheterization Requires Emergency Cardiac Operation. Thorac. Cardiovasc. Surg. 2013, 61, 610–611. [Google Scholar] [CrossRef] [PubMed]
  14. Webber, M.R.; Stiles, M.K.; Pasupati, S. Percutaneous repair of aortic puncture with Amplatzer closure device during attempted transseptal puncture. J. Invasive Cardiol. 2013, 25, E110–E113. [Google Scholar]
  15. Russo, G.; Taramasso, M.; Maisano, F. Transseptal puncture: Procedural guidance, challenging situations and management of complications. EuroIntervention 2021, 17, 720–727. [Google Scholar] [CrossRef]
  16. Hara, H.; Virmani, R.; Ladich, E.; Mackey-Bojack, S.; Titus, J.; Reisman, M.; Gray, W.; Nakamura, M.; Mooney, M.; Poulose, A.; et al. Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical Status. J. Am. Coll. Cardiol. 2005, 46, 1768–1776. [Google Scholar] [CrossRef]
  17. Gaita, F.; Corsinovi, L.; Anselmino, M.; Raimondo, C.; Pianelli, M.; Toso, E.; Bergamasco, L.; Boffano, C.; Valentini, M.C.; Cesarani, F.; et al. Prevalence of Silent Cerebral Ischemia in Paroxysmal and Persistent Atrial Fibrillation and Correlation with Cognitive Function. J. Am. Coll. Cardiol. 2013, 62, 1990–1997. [Google Scholar] [CrossRef]
  18. Alkhouli, M.; Sarraf, M.; Zack, C.J.; Holmes, D.R.; Rihal, C.S. Iatrogenic atrial septal defect following transseptal cardiac interventions. Int. J. Cardiol. 2016, 209, 142–148. [Google Scholar] [CrossRef]
  19. Schueler, R.; Öztürk, C.; Wedekind, J.A.; Werner, N.; Stöckigt, F.; Mellert, F.; Nickenig, G.; Hammerstingl, C. Persistence of Iatrogenic Atrial Septal Defect After Interventional Mitral Valve Repair with the MitraClip System. JACC Cardiovasc. Interv. 2015, 8, 450–459. [Google Scholar] [CrossRef]
  20. Chandraprakasam, S.; Satpathy, R. When to close iatrogenic atrial septal defect after percutaneous edge to edge repair of mitral valve regurgitation. Cardiovasc. Revasc Med. 2016, 17, 421–423. [Google Scholar] [CrossRef]
  21. Hildick-Smith, D.; McCready, J.; De Giovanni, J. Transseptal puncture: Use of an angioplasty guidewire for enhanced safety. Catheter. Cardiovasc. Interv. 2007, 69, 519–521. [Google Scholar] [CrossRef]
  22. Maisano, F.; La Canna, G.; Latib, A.; Godino, C.; Denti, P.; Buzzatti, N.; Taramasso, M.; Cioni, M.; Giacomini, A.; Colombo, A.; et al. Transseptal access for MitraClip® procedures using surgical diathermy under echocardiographic guidance. EuroIntervention 2012, 8, 579–586. [Google Scholar] [CrossRef] [PubMed]
  23. Hsu, J.C.; Badhwar, N.; Gerstenfeld, E.P.; Lee, R.J.; Mandyam, M.C.; Dewland, T.A.; Imburgia, K.E.; Hoffmayer, K.S.; Vedantham, V.; Lee, B.K.; et al. Randomized Trial of Conventional Transseptal Needle Versus Radiofrequency Energy Needle Puncture for Left Atrial Access (the TRAVERSE-LA Study). J. Am. Heart Assoc. 2013, 2, e000428. [Google Scholar] [CrossRef] [PubMed]
  24. Graham, A.J.; Honarbakhsh, S.; O’Brien, B.; Schilling, R.J. A Simplified Trans-Septal Puncture Technique using a Needle Free Approach for Cryoablation of Atrial Fibrillation. J. Atr. Fibrillation 2017, 10, 1628. [Google Scholar] [CrossRef] [PubMed]
  25. Tomlinson, D.R.; Sabharwal, N.; Bashir, Y.; Betts, T.R. Interatrial Septum Thickness and Difficulty with Transseptal Puncture during Redo Catheter Ablation of Atrial Fibrillation. Pacing Clin. Electrophysiol. 2008, 31, 1606–1611. [Google Scholar] [CrossRef]
  26. Cheng, E.P.; Liu, C.F.; Yeo, I.; Markowitz, S.M.; Thomas, G.; Ip, J.E.; Kim, L.K.; Lerman, B.B.; Cheung, J.W. Risk of Mortality Following Catheter Ablation of Atrial Fibrillation. J. Am. Coll. Cardiol. 2019, 74, 2254–2264. [Google Scholar] [CrossRef]
Figure 1. Essential echocardiographic projections for performing TSP. The bicaval view provides inferior-to-superior orientation (blue). The short-axis (SAX) view at the base allows for posterior-to-anterior orientation (yellow). The mid-esophageal 4-chamber view is utilized to assess the height of the TSP in relation to the mitral valve annulus (purple). SVC = superior vena cava, IVC = inferior vena cava, RA = right atrium, LA = left atrium, RV = right ventricle, LV = left ventricle, AV = aortic valve.
Figure 1. Essential echocardiographic projections for performing TSP. The bicaval view provides inferior-to-superior orientation (blue). The short-axis (SAX) view at the base allows for posterior-to-anterior orientation (yellow). The mid-esophageal 4-chamber view is utilized to assess the height of the TSP in relation to the mitral valve annulus (purple). SVC = superior vena cava, IVC = inferior vena cava, RA = right atrium, LA = left atrium, RV = right ventricle, LV = left ventricle, AV = aortic valve.
Complications 02 00014 g001
Figure 2. “Pull back technique” to approach the fossa ovalis. The pull-back technique for transseptal puncture involves advancing the needle and sheath assembly into the superior vena cava (SVC) under fluoroscopic and echocardiographic guidance. The assembly is then slowly withdrawn caudally while maintaining the needle orientation (e.g., at the 5–6 o’clock position) until tenting of the fossa ovalis is observed, performing three bumps. Proper tenting is confirmed with echocardiography and fluoroscopy, ensuring the optimal puncture site is reached before proceeding.
Figure 2. “Pull back technique” to approach the fossa ovalis. The pull-back technique for transseptal puncture involves advancing the needle and sheath assembly into the superior vena cava (SVC) under fluoroscopic and echocardiographic guidance. The assembly is then slowly withdrawn caudally while maintaining the needle orientation (e.g., at the 5–6 o’clock position) until tenting of the fossa ovalis is observed, performing three bumps. Proper tenting is confirmed with echocardiography and fluoroscopy, ensuring the optimal puncture site is reached before proceeding.
Complications 02 00014 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Azzola Guicciardi, N.; De Carlo, C.; Maisano, F. Transeptal Puncture Complications: What to Watch for and How to Avoid Them. Complications 2025, 2, 14. https://doi.org/10.3390/complications2020014

AMA Style

Azzola Guicciardi N, De Carlo C, Maisano F. Transeptal Puncture Complications: What to Watch for and How to Avoid Them. Complications. 2025; 2(2):14. https://doi.org/10.3390/complications2020014

Chicago/Turabian Style

Azzola Guicciardi, Nicolò, Carlotta De Carlo, and Francesco Maisano. 2025. "Transeptal Puncture Complications: What to Watch for and How to Avoid Them" Complications 2, no. 2: 14. https://doi.org/10.3390/complications2020014

APA Style

Azzola Guicciardi, N., De Carlo, C., & Maisano, F. (2025). Transeptal Puncture Complications: What to Watch for and How to Avoid Them. Complications, 2(2), 14. https://doi.org/10.3390/complications2020014

Article Metrics

Back to TopTop